Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER_GOV × Medication Adherence × Clear all

Phase

Status

Sponsor Class

OTHER 25 INDUSTRY 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 95 Neoplasms 65 Colorectal Neoplasms 49 Uterine Cervical Neoplasms 39 Prostatic Neoplasms 30 Stomach Neoplasms 28 Motor Activity 26 Carcinoma, Hepatocellular 21 Rectal Neoplasms 20 Lung Neoplasms 19 Head and Neck Neoplasms 17 Pancreatic Neoplasms 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 13 Pain 13 Brain Neoplasms 12 Pain, Postoperative 11 Recurrence 10 Lymphoma 10 Glioma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Pilonidal Sinus 9 Endometrial Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Anxiety Disorders 9 Thyroid Neoplasms 8 Ovarian Neoplasms 8 Esophageal Neoplasms 8 Radiation Injuries 7 Papillomavirus Infections 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05324020 2023-09-07

Edherence

Luxembourg Institute of Health

Phase NA Completed

Breast Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡